Vitreoretinal Technologies, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1999-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 2:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (50.0%)Phase 3
1 (50.0%)A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects
- First Posted Date
- 2009-05-27
- Last Posted Date
- 2009-10-20
- Lead Sponsor
- Vitreoretinal Technologies, Inc.
- Target Recruit Count
- 160
- Registration Number
- NCT00908778
- Locations
- 🇮🇳
LVPEI, Vizag, AP, India
🇮🇳Amrita, Kochi, India
🇲🇽La Ceguera, San Lucas, Coyoacan, Mexico
A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects
- First Posted Date
- 2008-04-22
- Last Posted Date
- 2009-10-20
- Lead Sponsor
- Vitreoretinal Technologies, Inc.
- Target Recruit Count
- 400
- Registration Number
- NCT00664183
- Locations
- 🇮🇳
LVPEI, Hyderabad, India
🇮🇳Sankara Nethralaya, Chennai, India
🇮🇳Aravind, Pondicherry, India
News
No news found